.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The MiG randomized trial compared metformin with insulin in women with gestational diabetes requiring pharmacologic treatment. Composite neonatal outcomes were not significantly different between groups, and many women preferred metformin because of its oral administration. However, a substantial proportion required supplemental insulin to achieve glycemic targets. For obstetricians and physicians, the study is useful because it frames metformin as one option rather than a universal replacement for insulin. Placental transfer, long-term offspring evidence, maternal preferences and local guidelines should be considered. Nutrition therapy, glucose monitoring and appropriate fetal surveillance remain essential regardless of medication choice. The practical message is that pharmacologic treatment should be individualized, with clear thresholds for escalation when glycemic control is inadequate. The trial also highlights the importance of shared decision-making in pregnancy, where convenience and patient acceptability need to be balanced against the evolving evidence base.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The MiG randomized trial compared metformin with insulin in women with gestational diabetes requiring pharmacologic treatment. Composite neonatal outcomes were not significantly different between groups, and many women preferred metformin because of its oral administration. However, a substantial proportion required supplemental insulin to achieve glycemic targets. For obstetricians and physicians, the study is useful because it frames metformin as one option rather than a universal replacement for insulin. Placental transfer, long-term offspring evidence, maternal preferences and local guidelines should be considered. Nutrition therapy, glucose monitoring and appropriate fetal surveillance remain essential regardless of medication choice. The practical message is that pharmacologic treatment should be individualized, with clear thresholds for escalation when glycemic control is inadequate. The trial also highlights the importance of shared decision-making in pregnancy, where convenience and patient acceptability need to be balanced against the evolving evidence base.
4 weeks back
Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month
Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back
